RNA interference has been envisaged as a powerful tool for molecular and clinical investigation with a great potential for clinical applications. In recent years, increased understanding of cancer biology and stem cell biology has dramatically accelerated the development of technology for cell and gene therapy in these areas. This paper is a review of the most recent report of innovative use of siRNA to benefit several central nervous system diseases. Furthermore, a description is made of innovative strategies of delivery into the brain by means of viral and non-viral vectors with high potential for translation into clinical use. Problems are also highlighted that might hamper the transition from bench to bed, analyzing the lack of reliable preclinical models with predictive validity and the lack of effective delivery systems, which are able to overcome biological barriers and specifically reach the brain site of action. © 2013 Springer Basel.

Novel siRNA delivery strategy: A new "strand" in CNS translational medicine? / Gherardini, Lisa; Bardi, Giuseppe; Gennaro, Mariangela; Pizzorusso, Tommaso. - In: CELLULAR AND MOLECULAR LIFE SCIENCES. - ISSN 1420-682X. - STAMPA. - 71:(2014), pp. 1-20. [10.1007/s00018-013-1310-8]

Novel siRNA delivery strategy: A new "strand" in CNS translational medicine?

BARDI, GIUSEPPE;GENNARO, MARIANGELA;PIZZORUSSO, TOMMASO
2014

Abstract

RNA interference has been envisaged as a powerful tool for molecular and clinical investigation with a great potential for clinical applications. In recent years, increased understanding of cancer biology and stem cell biology has dramatically accelerated the development of technology for cell and gene therapy in these areas. This paper is a review of the most recent report of innovative use of siRNA to benefit several central nervous system diseases. Furthermore, a description is made of innovative strategies of delivery into the brain by means of viral and non-viral vectors with high potential for translation into clinical use. Problems are also highlighted that might hamper the transition from bench to bed, analyzing the lack of reliable preclinical models with predictive validity and the lack of effective delivery systems, which are able to overcome biological barriers and specifically reach the brain site of action. © 2013 Springer Basel.
2014
71
1
20
Gherardini, Lisa; Bardi, Giuseppe; Gennaro, Mariangela; Pizzorusso, Tommaso
File in questo prodotto:
File Dimensione Formato  
review 12-2-13.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 610.88 kB
Formato Adobe PDF
610.88 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1015809
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 11
social impact